Cite
HARVARD Citation
Kaunitz, A. et al. (2020). 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial. Menopause. 27 (12), p. . [Online].